Abstract
Journal of Ocular Pharmacology and TherapeuticsVol. 30, No. 2-3 Featured ColumnEyes on New Product Development: Trabecular MeshworkGary D. NovackGary D. NovackSearch for more papers by this authorPublished Online:3 Apr 2014https://doi.org/10.1089/jop.2014.1505AboutSectionsView articleView Full TextPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail View article"Eyes on New Product Development: Trabecular Meshwork." Journal of Ocular Pharmacology and Therapeutics, 30(2-3), pp. 83–84FiguresReferencesRelatedDetailsCited bySubstituted Furanocoumarins as Novel Class of Antibacterial Translation InhibitorsCombinatorial Chemistry & High Throughput Screening, Vol. 22, No. 6An Independent Evaluation of a Novel Peptide Mimetic, Brilacidin (PMX30063), for Ocular Anti-Infective Regis P. Kowalski, Eric G. Romanowski, Kathleen A. Yates, and Francis S. Mah18 January 2016 | Journal of Ocular Pharmacology and Therapeutics, Vol. 32, No. 1 Volume 30Issue 2-3Mar 2014 InformationCopyright 2014, Mary Ann Liebert, Inc.To cite this article:Gary D. Novack.Eyes on New Product Development: Trabecular Meshwork.Journal of Ocular Pharmacology and Therapeutics.Mar 2014.83-84.http://doi.org/10.1089/jop.2014.1505Published in Volume: 30 Issue 2-3: April 3, 2014PDF download
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
